SCHEMBL4189918

SCHEMBL4189918

C[C@@H](CC1CCCC1)NCc1ccccc1NC(=O)c1cccs1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.57
MAPT P10636 2/20 0.57
HSD17B10 Q99714 2/20 0.49
RAB9A P51151 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
NPC1 O15118 2/20 0.46
MAPK1 P28482 2/20 0.46
APLNR P35414 1/20 0.45
TSHR P16473 5/20 0.44
NPSR1 Q6W5P4 2/20 0.44
LMNA P02545 1/20 0.44
BCHE P06276 3/20 0.44
POLB P06746 1/20 0.43
HPGD P15428 4/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
KDM4E B2RXH2 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
QRFPR Q96P65 1/20 0.42
CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4188002 0.99 ALDH1A1 (0.56) ALDH1A1MAPTHSD17B10RAB9AL3MBTL1
SCHEMBL14344009 0.99 ALDH1A1 (0.56) ALDH1A1MAPTHSD17B10RAB9AL3MBTL1
Hydrochloric Acid SCHEMBL4202482 0.98 ALDH1A1 (0.55) ALDH1A1MAPTHSD17B10RAB9AL3MBTL1
SCHEMBL4707714 0.91 MAPT (0.54) ALDH1A1MAPTHSD17B10L3MBTL1MAPK1
SCHEMBL14343745 0.88 ALDH1A1 (0.51) ALDH1A1MAPTHSD17B10RAB9ANPC1
SCHEMBL4188354 0.84 SMN1; SMN2 (0.46) ALDH1A1MAPTHSD17B10RAB9ANPC1
SCHEMBL4186552 0.84 ALDH1A1 (0.46) ALDH1A1MAPTHSD17B10MAPK1APLNR
SCHEMBL4197411 0.84 ACKR3 (0.47) ALDH1A1MAPTL3MBTL1LMNAPOLB
SCHEMBL4188174 0.84 ACKR3 (0.47) ALDH1A1MAPTL3MBTL1LMNAPOLB
SCHEMBL4186006 0.82 KMT2A (0.44) ALDH1A1MAPTHSD17B10RAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 ALDH1A1 2744/4885MAPT 2269/4885HSD17B10 2205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.